Adapting CRISPR/Cas9 System for Targeting Mitochondrial Genome

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• Mitochondrial gene editing is challenging due to inefficient delivery of CRISPR-Cas9 components.
• Targeting mitochondrial DNA (mtDNA) is crucial for treating various inherited diseases.

Purpose of the Study:

• To develop and validate a novel CRISPR-Cas9 delivery system for effective mitochondrial gene editing.
• To demonstrate sequence-specific cleavage of mitochondrial DNA and reduction of pathogenic gene expression.

Main Methods:

• Engineered a guide RNA (gRNA) with an RNA transport-derived stem loop element (RP-loop) for mitochondrial targeting.
• Expressed Cas9 enzyme fused with a mitochondrial localization sequence.
• Utilized cells with a specific 11205G variant in the NADH-ubiquinone oxidoreductase chain 4 (ND4) gene.

Main Results:

• Achieved mitochondrial colocalization of the RP-loop gRNA.
• Observed a significant reduction in ND4 gene expression in cells with the targeted variant.
• Reported a decrease in overall mitochondrial DNA (mtDNA) levels following gene editing.

Conclusions:

• The developed RP-loop gRNA system facilitates mitochondrial delivery and function of CRISPR-Cas9.
• This proof-of-concept study validates sequence-specific mtDNA cleavage and gene expression reduction.
• The findings support the potential of CRISPR-Cas9-mediated gene editing for treating mitochondrial diseases.